The evolution of insulin therapy.

Area of Science:

• Biochemistry
• Medical Engineering
• Pharmacology

Background:

• Insulin therapy has a century-long history, evolving from early purification challenges to modern recombinant DNA technology.
• Key milestones include understanding insulin's polypeptide nature, amino acid sequence, and 3D structure, enabling novel insulin development.
• Both clinical needs and technological advancements in chemical and mechanical engineering have consistently driven progress in insulin therapy.

Purpose of the Study:

• To review the historical evolution of insulin therapy.
• To highlight the interplay between clinical needs and technological advancements in shaping insulin treatment.
• To discuss the impact of scientific discoveries, including genetic engineering and mechanical innovations, on insulin development and delivery.

Main Methods:

• Historical review of scientific literature and technological developments in insulin therapy.
• Analysis of key discoveries in biochemistry, molecular biology, and engineering related to insulin.
• Examination of the progression of insulin purification, characterization, and manufacturing processes.

Main Results:

• Insulin therapy has progressed through distinct phases, including purification, structural elucidation, and recombinant DNA technology.
• Engineering innovations have led to improved insulin formulations and sophisticated delivery devices.
• While biological sciences have deepened understanding of insulin action, their clinical application in novel insulins is a recent development.

Conclusions:

• The evolution of insulin therapy is a testament to interdisciplinary progress, integrating biological insights with engineering solutions.
• Future advancements in insulin therapy will likely continue to be fueled by a combination of biological understanding and technological innovation.
• The journey of insulin therapy underscores its role as a pioneering pharmaceutical to benefit from genetic code advancements.